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The developmental progression of primordial germ cells (PGCs) to fully mature 
gametes involves extensive epigenetic changes which could be important for the gain 
of totipotency upon fertilization. Germ cells are also unique in that they can be 
reprogrammed to pluripotent embryonic germ cells (EGC) without the need for 
ectopic overexpression of any transcription factor if appropriate culture conditions are 
provided. Such plasticity to regain pluripotency or acquire totipotency could 
potentially be attributed to both transcriptional and epigenetic properties of germ 
cells, which are difficult to study on a genome-wide scale due to limited numbers of 
germ cells per embryo. In particular, it has been technically challenging to map 
histone modifications in germ cells as chromatin immunoprecipitation (ChIP) 
typically requires substantially high amounts of starting cell material. Using modified 
and optimized procedures, I purified germ cells from E13.5 male embryos, and 
performed chromatin immunoprecipitation (ChIP) coupled with a high-throughput 
sequencing technology. Genome-wide maps of H3K4me3, H3K27me3, H3K27ac and 
H2BK20ac have been generated for E13.5 male germ cells to enable the identification 
of active and poised regulatory elements, such as promoters and enhancers. In 
addition, expression profiling was performed on E11.5, E13.5 and E15.5 germ cells to 
study the transcriptional status/ changes of genes located near these regulatory 
elements, providing insight into the biological transitions that occur during this 
developmental period. Lastly, combining these datasets with motif enrichment 
analyses, potential germ cell regulators were identified and functionally validated in 
vitro.                                                (238 words) 
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7. Literature Review 
7.1. Stem cells and developmental potency 
Stem cells are characterized by an ability to self-renew and differentiate into a variety 
of cell types when provided with appropriate cues. Stem cells may be broadly 
categorized based on the developmental potency that they possess, from giving rise to 
only a single cell type (unipotency), multiple cell types of a particular lineage 
(multipotency), and all cell types of the embryo proper (pluripotency) (Jaenisch and 
Young, 2008). Totipotency refers to the ability to contribute to all lineages that are 
found in the embryo proper as well as extraembryonic tissues. In mammalian 
development, the zygote which forms upon fertilization as well as early blastomeres is 
totipotent. To date, there has been no report of totipotent stem cells that can be 
derived from vertebral organisms, cultured and maintained in vitro.  
Under normal circumstances, embryonic development proceeds in a unidirectional 
manner from totipotent/ pluripotent cells that have broad developmental capacity to 
cells that have a specific lineage-restricted cell identity. However, recent studies have 
demonstrated that it is possible to coerce differentiated somatic cells to reacquire 
pluripotency in vitro (Takahashi and Yamanaka, 2006). This expansion of 
developmental potency or alteration of cell fate is generally termed as 
reprogramming. Reprogramming can be achieved by various techniques, namely cell 
fusion, somatic cell nuclear transfer and induced pluripotency (Yamanaka, 2007). 
More recently, numerous studies have reported that somatic cells can also be directly 
transdifferentiated from one somatic cell type to another (Jopling et al., 2011). 
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7.2. Sources of pluripotent stem cells 
Early pluripotential studies originated from the observation that strain 129 mice have 
high incidence of testicular teratomas (Stevens and Little, 1954). It was later 
discovered that such teratocarcinoma properties could be attributed to a population of 
undifferentiated embryonal carcinoma (EC) cells (Kleinsmith and Pierce, 1964). 
Astonishingly, early mouse embryos when grafted into adult mice also resulted in 
teratocarcinoma formation (Solter et al., 1970; Stevens, 1970). Eventually in 1981, 
embryonic stem cells (ESCs) were directly derived from the inner cell mass (ICM) of 
mouse blastocysts (Evans and Kaufman, 1981; Martin, 1981). Unlike EC cells, mouse 
ESCs are karyotypically normal and give rise to germline chimeras (Bradley et al., 
1984). This demonstration of germline transmission of ESCs has leapt the ESC field 
to one in which genetic manipulations and derivation of stable mouse transgenic lines 
are possible. Moreover, germline transmission implies that ESCs can contribute to 
functional gametes in addition to somatic cells of the three germ layers and thus are 
truly pluripotent by definition. Slightly more than a decade ago, human ESCs were 
derived (Thomson et al., 1998) and ignited much excitement about potential 
therapeutic applications of ESCs in regenerative medicine. 
Besides ESC, other pluripotent cell types that include embryonic germ cells (EGCs) 
(Matsui et al., 1992; Resnick et al., 1992) and epiblast stem cells (EpiSCs) (Brons et 
al., 2007; Tesar et al., 2007) could be derived from early primordial germ cells 
(PGCs) and the post-implantation epiblast respectively. However, ESCs, EGCs and 
EpiSCs are all derived from early embryonic stages and thus not clinically feasible to 
obtain. The scarcity of human embryos, ethical concerns and advantages of 
autologous patient-specific pluripotent cells drives the motivation for newer methods 
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to derive pluripotent stem cells. Initial attempts through somatic cell nuclear transfer 
(Wilmut et al., 1997) and cell fusion (Cowan et al., 2005; Tada et al., 2001) were 
successful to a limited extent. Reprogramming via such methods was largely 
inefficient and generated new sets of problems such as developmental abnormalities 
(Tamashiro et al., 2002) and tetraploidy. In 2006, Yamanaka and colleagues 
reprogrammed mouse embryonic fibroblasts into induced pluripotent stem (iPS) cells 
via transduction with Oct4, Sox2, Klf4 and c-Myc (Takahashi and Yamanaka, 2006). 
Soon after, human iPS were derived using OCT4, SOX2, KLF4 and c-MYC (Park et 
al., 2008; Takahashi et al., 2007) or with the latter two factors replaced by NANOG 
and LIN28 (Yu et al., 2007).  
Following the pilot discovery of iPS, numerous groups have quickly replicated and 
improved the reprogramming technique. Thus far, iPS cell lines have been generated 
from various cell types including hepatocytes (Aoi et al., 2008), gastric epithelial cells 
(Aoi et al., 2008), neural progenitor cells (Mikkelsen et al., 2008), pancreatic β cells 
(Stadtfeld et al., 2008), lymphocytes (Hanna et al., 2008) and keratinocytes (Aasen et 
al., 2008). Efforts were also made to avoid genomic integration of the transgenes by 
introducing reprogramming factors as purified proteins (Kim et al., 2009a; Zhou et al., 
2009) or RNA (Warren et al., 2010) instead of through viral transduction. Notably, 
the complexity of reprogramming factor cocktail and efficiency of reprogramming 
depends on the intrinsic characteristics of the starting cell type. For example, while 
fibroblasts generally require three reprogramming factors if c-Myc is excluded 
(Nakagawa et al., 2008), neural stem cells can be reprogrammed to iPSC with Oct4 
alone (Kim et al., 2009b; Nakagawa et al., 2008). In addition, reprogramming 
efficiencies could be improved using chemical inhibitors of DNA methylases, histone 
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deacetylases and histone methylases (Feng et al., 2009b), suggesting that epigenetic 
alteration is also an important element of the reprogramming process. 
7.3. Mouse embryonic stem cells 
7.3.1. The core pluripotency factors and extended transcriptional 
network 
The ability to maintain ESC pluripotency and to direct de-differentiation during iPS 
reprogramming stems from our understanding of the molecular circuitry that underlies 
pluripotency. In ESC, the core transcriptional network comprises Oct4 (encoded by 
the Pou5f1 gene), Sox2 and Nanog which result in pronounced phenotypes upon 
knockout in vivo. Disruption of Pou5f1 caused the ICM to aberrantly differentiate into 
the trophectoderm lineage instead of the embryo proper (Nichols et al., 1998); Nanog-
null ICM failed to develop into the epiblast (Silva et al., 2009); Sox2 knockout mouse 
resulted in an early embryonic lethal phenotype (Avilion et al., 2003). Together, Oct4, 
Sox2 and Nanog promote pluripotency and self-renewal while suppressing 
differentiation (Boyer et al., 2005; Loh et al., 2006). In recent years, the ESC 
transcription network rapidly expanded to include other transcription factors such as 
Klfs (Jiang et al., 2008), Sall4 (Wu et al., 2006b), Zic3 (Lim et al., 2007; Wu et al., 
2006b), Tcf3 (Cole et al., 2008), Znf143 (Chen et al., 2008a) and Ronin (Dejosez et 
al., 2008). Large-scale or later genome-wide RNA-interference (RNAi) screens also 
led to new additions to the pluripotency network such as Esrrb, Tcf3, Tcl1 (Ivanova et 
al., 2006), Paf1c (Ding et al., 2009), Cnot3, Trim28a (Hu et al., 2009) and the 
mediator/ cohesin complexes (Kagey et al., 2010). 
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To gain insight into how these pluripotency factors maintain ESCs in a continually 
self-renewing yet undifferentiated state, it is helpful to identify their downstream 
target genes. Chromatin immunoprecipitation (ChIP)-based technologies have enabled 
the genome-wide mapping of binding sites of core pluripotency factors Oct4, Sox2 
and Nanog as well as other pluripotency-associated transcription factors and co-
regulators in mouse ESCs (mESCs) (Chen et al., 2008b; Kim et al., 2008). Co-
localization analyses revealed that pluripotency transcription factors can be clustered 
into two major groups: an Oct4-centric module (Oct4, Sox2, Nanog, Smad1, STAT3, 
Dax1, Nac1, Zfp281, Esrrb, Nr5a2, Tcfcp2l1 and Klf4) and a Myc-centric module (c-
Myc, n-Myc, E2F1, Zfx, Rex1 and Ronin). The Oct4-centric cluster co-localizes 
extensively with p300 which is commonly enriched at enhancer regions, and directly 
links the transcription network with the LIF/STAT3 and BMP4/Smad1 signaling 
pathways (Chen et al., 2008b). It was also shown that the strength of transcription 
regulation positively correlates with the number of transcription binding at the same 
site (Kim et al., 2008). Downstream target genes include a broad spectrum of 
molecules such as transcription factors, microRNAs, lincRNAs, chromatin-
remodelling and histone modifying proteins (Ng and Surani, 2011). Besides co-
regulating common target genes, the expanded repertoire of pluripotency transcription 
factors also autoregulate themselves and each other (Ng and Surani, 2011), 
contributing to a stabilized yet sensitive transcriptional network in ESCs. 
7.3.2. Epigenetic features of mouse ESCs 
Multiple lines of evidence suggest that the pluripotency transcriptional network is 
intricately intertwined to epigenetic regulation. For example, Oct4, Sox2 and Nanog 
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co-bind and co-regulate epigenetic factors such as Smarcad1, Myst3, Eset, Eed, 
Suz12, and Phc1 (Endoh et al., 2008; Loh et al., 2006). The interaction between 
transcription factors and epigenetic regulators is bi-directional such as the case 
whereby Oct4 binds to the Jmjd1a and Jmjd2c genes, which encode for H3K9 
demethylases that in turn regulate the expression of pluripotent genes such as Nanog 
and Tcl1 in mESCs (Loh et al., 2007). Besides H3K9 methylation, DNA methylation 
is also an important epigenetic mark to silence pluripotency genes such as Pou5f1, 
Nanog, Lefty1 and Tdgf1 (Farthing et al., 2008), and must be actively erased during 
reprogramming by an activation-induced cytidine deaminase (AID)-mediated 
mechanism (Bhutani et al., 2010). On this note, it is rather surprising that global CpG 
methylation patterns are relatively similar between mESC and differentiated cell types 
(Meissner et al., 2008).  
In general, the chromatin state of mESCs can be described as hyperdynamic and 
structurally relaxed (Meshorer and Misteli, 2006). Mouse ESCs also have higher 
levels of H3K9ac than somatic cells, corresponding to an open chromatin that is 
transcriptionally permissive (Mattout and Meshorer, 2010). In addition, active 
H3K4me3 and repressive H3K27me3 epigenetic marks were found to co-localize at 
highly conserved noncoding elements (HCNEs) in mouse ESCs (Azuara et al., 2006; 
Bernstein et al., 2006). The term bivalent is now used to describe such H3K4me3 and 
H3K27me3-marked regions, which are often enriched in genes with developmental 
functions and are expressed at low levels in ESCs. Initially thought as an ESC-
specific feature, bivalent domains were later shown to exist in other differentiated cell 
types as well (Mikkelsen et al., 2007). It is postulated that bivalent marks keep 
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developmental genes poised for activation and they resolve to either H3K4me3 or 
H3K27me3 upon differentiation. 
7.4. Germ cells: specification, migration and differentiation 
At the proximal posterior epiblast, PGC precursors receive bone morphogenetic 
protein (BMP) signals from the surrounding extraembryonic tissues. At E6.25, a few 
cells begin expressing Blimp1 which represses Hoxb1 and other mesodermal genes 
(Ohinata et al., 2005). These Blimp1-positive cells represent lineage-restricted PGCs 
that eventually give rise to about 40 Stella-positive PGCs (Ohinata et al., 2005) at 
E7.25 (Illustration 1). Soon after at around E7.5, PGCs begin migration from the 
proximal epiblast to eventually arrive at the developing gonad at around E10.5 to 
E11.5 (Richardson and Lehmann, 2010). During migration, PGCs continuously 
proliferate and undergo global epigenetic changes (Sasaki and Matsui, 2008; Tam and 
Snow, 1981). Cells that fail to arrive at the gonad would undergo programmed cell 
death to safeguard against development of germline teratomas and this process 
involves factors such as Dnd, p53 and Bax (Richardson and Lehmann, 2010). Over 
the next two days, the post-migratory germ cells receive signals from the neighboring 
gonadal somatic cells (Sertoli and Leydig in male gonads; Granulosa cells in female 
gonads), undergo sex determination and commit to either oogenesis or 
spermatogenesis (Kocer et al., 2009). By E12.5-E13.5, testis cords can be visualised 
in the male gonads. At E13.5, male germ cells undergo mitotic arrest while female 
germ cells initiate meiosis. These sex-dependent cell cycle changes depend on both 
signaling from gonadal somatic cells as well as activation of intrinsic factors that 
suppress meiosis and/or initiate differentiation of male germ cells, such as Nanos2, 
Dazl and Ddx4 (Lin and Page, 2005; Suzuki and Saga, 2008; Tanaka et al., 2000). 
 
 
Illustration 1: Germ cell development. Chronology of major events in germ cell 
development that include specification, migration, sex determination and sex-specific 
differentiation. Adapted from Sasaki and Matsui, Nature Review Genetics 2008.  
 
7.4.1. Transcriptional network 
Besides Blimp1, which specifies germ cell commitment by suppressing differentiation 
to other lineages (Ohinata et al., 2005), Prdm14 is also expressed in early PGCs at 
E6.75 (Yamaji et al., 2008). Prdm14-null mice are sterile due to a defect in germ cell 





mesodermal program but instead is essential for activating pluripotency-associated 
factors and epigenetic reprogramming in germ cells (Yamaji et al., 2008). 
Following gastrulation from about 8.5 d.p.c onward, Pou5f1 (encoding the Oct4 
protein) expression is confined to germ cells (Scholer et al., 1990). In males, Pou5f1 
expression is maintained until the formation of type A spermatogonia after birth. In 
females, Pou5f1 is downregulated when female germ cells enter meiosis and 
reactivated upon oocyte maturation (Pesce et al., 1998). The germ cell-specific 
expression of Pou5f1 is striking given the well-established roles of Oct4 as a 
pluripotency factor in the early embryos and mESCs (Nichols et al., 1998; Niwa et al., 
2000), as well as its role in inducing reprogramming of somatic cells (Takahashi and 
Yamanaka, 2006). Notably, germ cell-specific depletion of Pou5f1 resulted in an 
apoptotic response between 9.5 to 10.5 d.p.c, suggesting that Oct4 may be involved in 
regulating PGC survival (Kehler et al., 2004). The cell death phenotype, rather than 
differentiation, also indicates that Oct4’s functions in germ cells may differ from that 
in the ICM (Kehler et al., 2004).  
Other than Pou5f1, another core pluripotency factor Nanog is also expressed in PGCs. 
Initially repressed in E7.25-E7.5 PGCs, Nanog expression becomes detectable in 
migratory PGCs of both sexes and subsequently repressed again in E13.5 female germ 
cells that begin to undergo meiosis and in E14.5-E16.5 male germ cells that are 
undergoing mitotic arrest (Yamaguchi et al., 2005). Nanog-null PGCs failed to 
progress beyond E11.5, and hence Nanog is functionally implicated in the execution 
of germ cell development after PGCs arrive at the gonad (Chambers et al., 2007). 
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Knowledge of the transcriptional network of PGCs and post-migratory germ cells is 
rather limited to a handful of factors due to several reasons: the inaccessibility and 
limited numbers of germ cell per embryo, heterogeneity and dynamic nature of germ 
cells from pre-migratory to post-migratory, as well as the lack of a robust and 
convenient in vitro model system. While in vitro studies may not provide an exact 
reflection of in vivo events, they provide useful platforms for screening novel 
regulators of germ cells. For example, West et al. performed RNAi-mediated 
knockdown of candidate genes on in vitro generated germ cells. Due to a lack of a 
marker that is specific to early germ cells but not expressed in ESCs, potential germ 
cell regulators have to be indirectly screened by quantifying the number of EGC 
colonies formed after culture-mediated conversion (West et al., 2009). Using this 
method, they discovered a role of Lin28 in germ cell formation in vitro and further 
validated that Lin28 knockdown reduced germ cell numbers by E12.5. 
7.4.2. Epigenetic reprogramming in germ cells 
Germ cells undergo extensive epigenetic reprogramming during and after their 
migration into the genital ridges (Illustration 2). These epigenetic changes are pivotal 
for parental imprint erasure and X-chromosome reactivation, and potentially prime 
germ cells for the reacquisition of totipotency (Sasaki and Matsui, 2008). In migratory 
germ cells, H3K9 methyltransferase GLP (also known as Ehmt1) is downregulated at 
E7.25 followed by a reduction of the repressive H3K9me2 mark which reaches very 
low levels by E8.75 (Seki et al., 2005; Seki et al., 2007). At around the same time, 
H3K27me3 signals are strongly elevated at E8.5-E9.0 and remain at relatively high 
levels as compared to neighboring somatic cells at least until E12.5 (Seki et al., 2005).  
 Illustration 2: Epigenetic reprogramming in PGCs. Dashed bars indicate lower 
levels of the specified epigenetic modifications as compared to solid bars. Adapted 
from Sasaki and Matsui, Nature Review Genetics 2008.  
 
During the period when H3K9me2 is present at a low level and when H3K27me3 is 
not yet elevated, PGCs exhibit repression of RNA polymerase II-dependent 
transcription (Seki et al., 2007). Other than changes in histone modifications, germ 
cells also undergo two rounds of DNA demethylation at E8.0 and when germ cells 
arrive at the genital ridges at around E12.5 (Seki et al., 2005). By E13.5, both male 
and female germ cells are exceedingly hypomethylated with DNA methylation 
reaching levels that are even lower than methylation-deficient mESCs (Popp et al., 
2010). Global DNA demethylation in germ cells between E8.0 to E13.5 have been 
associated with passive mechanisms such as absence of the maintenance 
methyltransferase Dnmt1 at around E8.0 accompanied by low levels of de novo 
methyltransferase Dnmt3a and Dnmt3b, as well as active mechanisms that are 
dependent on the cytidine deaminase AID (Popp et al., 2010; Seki et al., 2005). 





and DNA methylation, and gain H3K27me3 which is a repressive mark characteristic 
of bivalent domains and is associated with greater plasticity. It is tantalizing to 
speculate that such “permissive” epigenetic landscape of germ cells may explain why 
early germ cells readily convert to pluripotent EGCs in culture. After E13.5, 
epigenetic events include the re-establishment of imprints after mitotic arrest for male 
germ cells and during post-natal oocyte growth for female germ cells (Reik et al., 
2001). H3K4 methylation by Prdm9 was also shown to be necessary for meiosis in 
both male and female germ cells (Hayashi et al., 2005). 
7.4.3. Conversion of germ cells to pluripotent stem cells  
Primordial germ cells are unipotent cells which are committed to the germ lineage, 
eventually differentiating into male or female gametes. The fusion of the mature male 
and female gametes, also known as the sperm and oocyte, will generate a totipotent 
zygote which has the capacity to give rise to all cell types of the embryo proper as 
well as extra-embryonic cell types. Apart from its natural ability to regain totipotency 
upon fertilization, PGCs may be reprogrammed by in vitro culture conditions to 
generate pluripotent embryonic germ cell lines (Matsui et al., 1992; Resnick et al., 
1992). Unlike the unipotent PGCs, pluripotent EGCs can give rise to germline 
chimeras when injected into the blastocyst (Labosky et al., 1994; Stewart et al., 1994). 
To date, germ cells are the only cell type that can be reverted back to a pluripotent 
stem cell simply by providing the appropriate culture system. Remarkably, this 
conversion does not require the overexpression of any transcription factor and occurs 
relatively rapidly in 7 to 10 days (Durcova-Hills et al., 2008; Matsui et al., 1992; 
Resnick et al., 1992). Early experimentations led by two independent groups converge 
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on the same cocktail of three culture supplements that are essential for the reversion 
of unipotent PGCs to pluripotent EGCs: leukemia inhibitory factor (LIF), stem cell 
factor (SCF) and basic fibroblast growth factor (bFGF) (Matsui et al., 1992; Resnick 
et al., 1992). Both LIF and SCF promote survival and proliferation of germ cells 
(Dolci et al., 1991; Godin et al., 1991; Matsui et al., 1991; Pesce et al., 1993), but 
together are insufficient to sustain germ cell culture beyond 7 days (Donovan et al., 
1986; Matsui et al., 1991). The inclusion of bFGF is critical for the formation of 
tightly packed alkaline phosphatase (AP)-positive EGC colonies that resemble mESC 
(Matsui et al., 1992; Resnick et al., 1992). It was later shown that the effect of bFGF 
can also be achieved with Trichostatin A (TSA) which is an inhibitor of histone 
deacetylases (Durcova-Hills et al., 2008). Both bFGF and TSA result in the 
downregulation of Blimp1 and hence de-repression of c-Myc and Klf4 (Durcova-Hills 
et al., 2008). Peculiarly, the efficiency of EGC conversion drastically declines as germ 
cells progress from E8.5 to E12.5 (Labosky et al., 1994; Matsui et al., 1992). For 
EGCs that were obtained from E12.5 embryos, all were of male origin and none were 
from female gonads (Labosky et al., 1994). Therefore, it is likely that early migratory 
PGCs differ from post-migratory gonadal germ cells in terms of responsiveness to 
growth factors in culture, and this change might be more prominent for female germ 
cells by E12.5. 
7.5. Histone modifications and regulatory elements 
Comparative analyses of genome sequencing data revealed that only less than half of 
the evolutionary conserved regions lie within protein-encoding regions (Chinwalla, 
2002; Siepel et al., 2005). Among these highly conserved non-coding regions lie 
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functional regulatory elements such as promoters and enhancers. Located immediately 
upstream of transcriptional start sites (TSS), promoters are sites bound and regulated 
by both transcription factors and the transcriptional initiation machinery (Visel et al., 
2009b). Enhancers are characteristically bound of a high density of transcription 
factors, and activate promoters by the recruitment of coactivators which leads to DNA 
looping (Visel et al., 2009b). However, unlike promoters, enhancers can be located 
distant from the TSS and function in an orientation-independent manner.  
Over the years, numerous studies have shown that the combinatorial occurrence of 
specific histone modifications is predictive of the type and activity of regulatory 
elements. For example, H3K4me3 was found to be enriched at promoters, but it’s 
correlation to expression of downstream genes depends on the GC content of the 
promoter region (Mikkelsen et al., 2007). Enhancers are characterized by lower levels 
of H3K4me3, higher levels of H3K4me1 and binding by p300 (Heintzman et al., 
2007; Visel et al., 2009a). As compared to promoters, activation of enhancers 
exhibited greater cell-type specificity (Heintzman et al., 2009; Visel et al., 2009a). 
Among the histone modifications, H2BK20ac (Shyam et al. unpublished data) and 
H3K27ac (Creyghton et al., 2010; Rada-Iglesias et al., 2011) have been associated 
with active promoters/ enhancers while H3K27me3 occurs at bivalent promoters/ 
enhancers (Azuara et al., 2006; Bernstein et al., 2006) that are poised for activation or 
repression during development/ differentiation.  
 
 
7.6. ChIP-Seq and its technical limitations 
ChIP is a powerful method for studying the association of transcription factors or 
chromatin-associated factors to DNA. The presence of histone modifications at 
nucleosomes can also be detected with ChIP. Succinctly, ChIP involves the 
enrichment of fragmented crosslinked protein-DNA complexes by using an antibody 
that specifically pulls down the protein/ histone mark of interest. Following de-
crosslinking, the purified DNA fragments can then be quantified with qPCR (ChIP-
qPCR), microarray (ChIP-Chip) or high-throughput sequencing (ChIP-Seq) 
(Illustration 3). ChIP-Seq surpasses ChIP-Chip in several aspects such as higher 
resolution, flexibility in sequencing depth and greater genomic coverage (Park, 2009). 
However, success in ChIP-Seq is still dependent on antibody quality and sample 
quantity. Sequencing costs, sequencing artifacts/ bias and massive data management 
are also issues of concern for ChIP-Seq. 
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Illustration 3: Schematic overview of 
ChIP-Chip and ChIP-Seq.  
The crosslinked DNA-protein complexes 
from either cell culture or tissue samples 
are sheared followed by 
immunoprecipitation with an antibody 
that binds the protein of interest. After 
reversal of crosslinks, enrichment of 
DNA fragments can be detected by 
hybridization to microarrays (ChIP-
Chip) or coupled to massively parallel 
sequencing (ChIP-Seq). Adapted from 
Visel et al., Nature 2009. 
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Although the amount of DNA input required for ChIP-Seq has been significantly 
reduced as compared to the antecedent ChIP-Chip method, at least 10-50 ng of 
immunoprecipitated DNA is still needed for each sample (Park, 2009) and this would 
translate to a typical starting material of millions of cells. Unlike cell culture systems 
that provide abundant material for ChIP, it is challenging to achieve similar amounts 
of ChIP-DNA from small cell populations such as cell types that can only be purified 
from in vivo. 
7.7. Current knowledge gap and research objectives 
Given the unique “plasticity” and extensive epigenetic reprogramming of germ cells, 
it would be informative to map histone modifications on a genome-wide manner. Due 
to technical challenges such as limited numbers of germ cells, previous studies have 
largely only analyzed epigenetic changes on a global level by immunostaining and 
western blots (Seki et al., 2005; Seki et al., 2007), and the chromatin state at precise 
genomic locations has remained elusive.  
As it is neither feasible nor cost-effective to purify germ cells on such as large-scale, 
it is necessary to modify and optimize the germ cell isolation and ChIP procedures for 
small sample quantities. In this project, I will demonstrate the feasibility of a modified 
small-scale ChIP-Seq procedure and use the optimized method to map several histone 
modifications including H3K4me3, H3K27me3, H3K27ac and H2BK20ac in purified 
fetal male germ cells. These histone modification data would elucidate the epigenetic 
landscape in germ cells as well as reveal genomic locations and activity status of 
regulatory elements (promoters and enhancers) that are active, repressed and poised in 
germ cells. Going further, motif enrichment analyses would also be performed on the 
25 
 
germ cell regulatory elements to uncover potential regulators of germ cell 
development. In addition to ChIP-Seq, I will perform microarray to profile 






8. Material and Methods 
8.1. Purification of germ cells 
Gonads were microscopically dissected from E13.5 embryos, which were derived 
from the intercross between male Pou5f1-GFP male mice (Jackson’s lab, stock no. 
004654) and female wild type CD1 mice. Gonads were treated with 0.25% Trypsin-
EDTA (Gibco) for 10-15 min at 37°C, with occasional pipetting to aid dissociation, 
and trypsin was inactivated by addition of 15% Fetal Bovine Serum (FBS)/ DMEM 
(Gibco). Cells were filtered through 40 µm cell strainers (BD Falcon) to obtain single 
cell suspension for FACS sorting (FACSAria II SORP, BD Bioscience). 
8.2. ChIP assay 
ChIP assays were performed as previously described (Loh et al., 2006). Cells were 
crosslinked with 1% formaldehyde for 8 min at room temperature and the 
formaldehyde was quenched with 125 mM glycine. FACS-purified cells were fixed, 
quenched and rinsed with TBSE buffer twice before storage at -80°C until sufficient 
cell numbers are accumulated for ChIP experiments. Chromatin was sonicated using 
the bioruptor (Diagenode) and chromatin extracts were immunoprecipitated with anti-
H3K4me3 (04-745, Millipore), anti-H3K27me3 (07-449, Millipore), anti-H3K27ac 
(ab4729, Abcam) and H2BK20ac (ab52988, Abcam) antibodies. Following de-
crosslinking, small-scale ChIP samples were subjected to an additional 15 cycles of 
amplification using the GenomePlex Single Cell Whole Genome Amplification Kit 
(WGA4, Sigma), and further purified using the QIAquick PCR purification kit. For all 
ChIP experiments, quantitative PCR (qPCR) analyses were performed in real-time 
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using the ABI PRISM 7900 Sequence Detection System and SYBR Green Master 
Mix (ABI). Relative occupancy values were determined by calculating the 
immunoprecipitation efficiency (ratios of the amount of immunoprecipitated DNA to 
that of the input sample). Small-scale ChIP samples were subjected to two rounds of 
BpmI restriction digestion to excise PCR adaptors prior to ChIP-Seq library 
preparation. For ChIP-Seq library preparation (ChIP-Seq DNA Sample Prep Kit IP-
102-1001, Illumina), 5-15 ng of ChIP DNA (as quantified by Picogreen assay) was 
used for end-repair and adaptor ligation followed by 15 cycles of amplification. 200-
300 bp size fragments were selectively cut from the agarose gel and purified using the 
Qiagen gel extraction kit. The extracted DNA was subjected to ChIP-Seq sequencing 
for 36 cycles according to the manufacturer’s instructions (Illumina). 
8.3. Microarray sample preparation from small quantities of RNA 
RNA was extracted from FACS-purified cells using the Arcturus PicoPure RNA 
Isolation Kit (Applied Biosystems) with on-column DNase treatment to eliminate 
potential DNA contamination. RNA quality was assessed using the RNA 6000 Pico 
LabChip Kit (Agilent) and quantitated using the Quant-iT RiboGreen RNA Reagent 
(Invitrogen). 10 ng of good-quality RNA, as defined by RIN value greater than 9.0, is 
amplified using the Ovation RNA Amplification System V2 (NuGEN) and purified 
using the Zymo Research DNA Clean & Concentrator-25 kit. Biotin-labelling was 
performed by incubating 5 ug of the amplified cDNA with UNG enzyme (Epicentre 
Biotechnologies) at 50°C for 30 min. Labelling buffer (0.952 M acetic acid and 28 
mM MgCl2) and ARP solution (Molecular Probes) was added and the mixture was 
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incubated at 50°C for 1 h, followed by a final purification using the Zymo Research 
DNA Clean & Concentrator-25 kit. 
1.5 µg of biotin-labelled cDNA was hybridized to microarrays (MouseWG-6 
Expression BeadChip version 2.0) at 48°C, according to NuGEN’s recommendation. 
Subsequent microarray chip processing was performed according to Illumina’s 
instructions and the arrays were scanned with the Illumina microarray platform. Three 
biological replicate microarray data was generated for E11.5, E13.5 and E15.5 germ 
cells and E13.5 GFP-negative cells were used as control. Differentially expressed 
genes were selected based on Significance Analysis of Microarrays (SAM) (Stanford 
University)  using the following criteria: detection probability greater than 0.95; fold 
change (FC) < 0.6 for downregulated genes, FC > 1.5 for upregulated genes and q-
value < 1%. Expression heatmaps were plotted using the Cluster 3.0 software and 
Java TreeView (Stanford University) and gene ontology analysis were performed 
using DAVID Bioinformatics Resources 6.7 (NIH) (Huang et al., 2008, 2009). 
8.4. Cell culture 
E14 mESCs were cultured on gelatin-coated dishes in Dulbecco’s modified Eagle 
medium (DMEM, GIBCO), supplemented with 15% heat-inactivated fetal bovine 
serum (FBS,GIBCO), 0.055 mM β-mercaptoethanol (GIBCO), 2 mM L-glutamine 
(GIBCO), 0.1 mM MEM nonessential amino acid (GIBCO), 20 μg ml-1 gentamicin 
(GIBCO) and 1,000 units ml-1 of LIF (Chemicon). Mouse ESCs were routinely 
passaged every 2 - 3 days at a splitting ratio of 1:8. v6.4 mouse ESCs and established 
stable cell lines were cultured on mitomycin C-treated MEF feeders in the same ES 
cell medium and passaged every 2 - 3 days. MEFs were isolated from E13.5 embryos 
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by dissociation in 0.05% trypsin at 37 ºC for 10 min and cultured in 15% FBS-
DMEM containing 20 μg ml-1 gentamicin. 293T cells were cultured in 10% FBS-
DMEM containing 20 μg ml-1 gentamicin. 
8.5. Transient transfection of mouse ESCs 
Transfection of E14 mESCs with knockdown or overexpression plasmids was 
performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
instructions. Briefly, 2 µg of plasmid was used to transfect each 6-well of mESCs, 
approximately 6 h after cell seeding. Transfected cells were selected with 1.0 µg ml-1 
of puromycin 12 h later, with a change of fresh selection media every day for the next 
3 days before RNA is harvested for downstream analysis. CDS of Nr5a2 and Dmrt1 
were amplified from E14 mESC cDNA and cloned into the pCAG.puro vector for 
overexpression purposes. shRNA oligos were designed and cloned into the 
AgeI/EcoRI cutting site of the pLKO.1 puro vector (Addgene) according to the 
manufacturer’s instructions.  
Target sequences used for RNAi are as follows:  
Luci shRNA - GATGAAATGGGTAAGTACA;                                                                                    
Nr5a2 shRNA - GCAAGTGTCTCAATTTAAA;                                                                          
Dmrt1 shRNA1 - CGGCAGGGTTTGTTGTTATTT;                                                      





8.6. Packaging of lentivirus and establishment of stable mES cell lines 
293T cells were co-transfected with pLKO.1 puro vectors or PL-SIN-EOS-C(3+)-EiP 
(Addgene), and viral packaging plasmids which include pCMV-VSV-G and R8.91. 
Transfection mix was replaced with 10% FBS-DMEM after 6 h and viral supernatant 
was harvested twice, once at 24 h and again at 48 h. The combined supernatant was 
filtered (0.45 µm) and concentrated using centrifugal filter columns (Millipore). To 
establish stable reporter/ knockdown cell lines, v6.4 mESCs were incubated with 
concentrated viruses in ES cell medium containing 8 µg ml-1 polybrene. After 24 h, 
medium was replaced with 1.0 µg ml-1 of puromycin selection medium. Cells were 
maintained/ passaged in selection medium for 1-2 weeks, before GFP-positive 
colonies were picked and transferred to feeder MEF for expansion and 
characterization as individual cell lines.  
8.7. RNA extraction, reverse transcription and quantitative real-time PCR 
Total RNA from cell culture was extracted using TRIzol Reagent (Invitrogen) and 
purified by isopropanol precipitation. Potential DNA contamination was eliminated 
by DNase I (Ambion) treatment at 37°C for 30 min, followed by EDTA inactivation 
at 65°C for 10 min. Reverse transcription was performed using SuperScript II Kit 
(Invitrogen). Quantitative PCR analyses were performed using a real time ABI 
PRISM 7900 Sequence Detection System and SYBR Green Master Mix.  
8.8. Luciferase reporter assay 
Selected enhancer fragments were PCR-amplified from E14 mESC genomic DNA 
and cloned downstream of the firefly luciferase, between the BamHI and SalI cutting 
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sites of a modified pGL3 basic vector. The modified pGL3 basic vector contains a 
475 bp Oct4 minimal promoter fragment cloned upstream of the firefly luciferase 
gene. EGC or 293T cells were co-transfected with 300 ng of sequence-verified 
reporter construct and 0.5 ng Renilla luciferase construct (pRLCMV; Promega), and 
selected with 1.0 µg ml-1 of puromycin 12 h later.  Firefly and Renilla luciferase 
activities were measured 48 h after transfection using the Glomax Multi-Detection 
System (Promega). Firefly/ Renilla ratios of tested enhancer regions were normalized 
to that of minimal promoter-only control. 
8.9. EB-mediated in vitro differentiation  
Mouse ES cells were trypsinized and cultured in non-coated 96 wells overnight in 
embryoid body (EB)  medium (ES cell medium without β-mercaptoethanol and LIF, 
with 1.0 µg ml-1 of puromycin for selection). On day 1, the formed EBs were 
transferred into non-coated Petri dishes, and cultured for up to an additional 6 days. 
EB dissociation was performed as described previously (West et al., 2006) and GFP-
positive cells were FACS-purified for RNA harvest or EGC conversion. For EGC 
conversion, sorted cells were cultured on feeder MEFs in mouse ES medium 
containing 15 ng ml-1 bFGF (Invitrogen), 30 ng ml-1 SCF (R&D Systems) and 5 µM 
retinoic acid (RA, Sigma). After 5-7 days of culture, alkaline phosphatase detection 
was performed using a commercial ESC characterization kit (Chemicon) according to 




9. Results and Discussion 
9.1. Purification of germ cells with high stringency 
It is essential to obtain pure populations of germ cells for downstream experiments. 
To purify mouse germ cells as material for ChIP and microarray, E13.5 gonads were 
dissected from Pou5f1-GFP transgenic mouse embryos that express GFP driven by 
the Pou5f1 promoter. The Pou5f1-GFP reporter construct comprises 18 kb of the 
endogenous Oct4 genomic region but the proximal enhancer was deleted such that 
GFP expression is specifically activated in the ICM and germ cells, but not in the 
epiblast and other somatic cell types (Yeom et al., 1996). Given that germ cells 
exhibit sex specific differences after their arrival at the genital ridge, gonads were 
sexed according to the pattern of GFP expression so that male and female gonads 
were harvested separately. GFP-positive germ cells are organized within the testis 
cords in male gonads while GFP-positive germ cells are uniformly distributed in the 
female gonad (Figure 1a-b, d-e). Dissociation of the male and female gonads was 
optimized to yield single cell suspension (Figure 1c, f) for Fluorescence Activated 
Cell Sorting (FACS). The dissociated gonadal cells comprise a large population of 
GFP-negative cells and a visually distinct GFP-positive population (Figure 2). 
Interestingly, sex-specific differences were also observed in the GFP intensity of the 
GFP-positive population, with male germ cells being brighter than female germ cells. 
The GFP-positive fraction was routinely isolated as germ cells using a highly 
stringent threshold and the purity of GFP-positive cells is always in excess of 95% as 
indicated by post-sort analyses (Figure 2b). To validate that the Pou5f1-GFP reporter 




Figure 1: Isolation of gonads from Pou5f1-GFP transgenic mice. Phase and GFP 
fluorescence images of E13.5 (a,d) male gonads, (b, e) female gonads and (c, f) 
dissociated gonadal cells.  
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 Figure 2: FACS purification of germ cells with high stringency. (a) GFP 
fluorescence histogram of dissociated gonadal cells isolated from E13.5 wild type 
control embryos and Pou5f1-GFP transgenic embryos. (b) Scatterplot distribution of 





post-sort results accurately reflects the efficiency of FACS purification, anti-Oct4 
immunostaining was performed on the FACS- purified GFP-positive cells (Figure 3). 
Indeed, the GFP-positive cells also express the Oct4 protein.  
9.2. Expression profiling of purified germ cells 
9.2.1. Isolation of microarray-grade RNA from purified germ cells 
To gain an understanding of transcriptional changes in male germ cells after their 
arrival at the developing gonad, germ cells were purified from E11.5, E13.5 and 
E15.5 embryos. In addition to counting the number of days-post-coitum, the 
developmental stage of embryos was also visually monitored (Figure 4). At 11.5 
d.p.c., the gonad is still developing structurally and testis cords are not formed, hence 
the gonad cannot be sexed based on visual observation. Furthermore, the sexual 
identity of germ cells is only established between 11.5 to 13.5 d.p.c. (Kocer et al., 
2009), depending on the signals received from the neighboring supportive somatic 
cells of the gonad. Hence, while male gonads were used for E13.5 and E15.5 germ 
cell purification, GFP-positive germ cells were harvested from E11.5 gonads 
regardless of the sex of the embryos. 
Due to the small number of GFP-positive germ cells that can be sorted from embryos, 
optimization of RNA harvesting methods was essential to maximize the amount of 
total RNA purified. The Picopure RNA isolation kit outperforms the standard Trizol-
Isopropanol precipitation method as the RNA yield was increased by more than 5 fold 
when only approximately 4,300 cells were used as input (Figure 5a). However, this 




Figure 3: Validation of Oct4 expression in FACS-purified Pou5f1-GFP positive 
germ cells. (a) Oct4 immunostaining (b) Pou5f1-GFP (c) Hoechst (d) merged image 







Figure 4: Development of the gonad from 11.5 d.p.c. to 15.5 d.p.c. Embryos and 
dissected gonads at (a,d) 11.5 d.p.c., (b,e) 13.5 d.p.c. and (c,f) 15.5 d.p.c.  
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Figure 5: Harvesting microarray-grade RNA from FACS-purified germ cells. (a) 
Comparison of RNA yield using the Trizol method and Picopure RNA isolation kit 
(Arcturus) from approximately 4,300 E13.5 male germ cells (E13.5M) and 16,000 
E13.5 female germ cells (E13.5F). RNA quantities were determined using the Quant-
iT RiboGreen RNA Reagent. Data represents the mean ± s.e.m. of two independent 
experiments (n = 2). (b, c) Agilent RNA 6000 Pico electropherogram showing two 
distinct ribosomal bands/ peaks corresponding to 18S and 28S rRNA. A RIN index 





16,000 cells. Overall, the Picopure RNA isolation kit is superior to the Trizol method 
when RNA is isolated from small cell populations. As estimation, it is possible to 
isolate more than 20 ng of total RNA from less than 5,000 sorted germ cells.  
The quality of isolated RNA was examined using the RNA 6000 Pico LabChip Kit. 
The two distinct bands on the gel electropherogram (Figure 5b,c) which represents the 
18S and 28S rRNA, and a uniformly low baseline, indicates good quality RNA with 
little degradation and the absence of DNA contamination. The RNA Integrity Number 
(RIN) is a number system that is commonly used to grade RNA quality, with 1 being 
the most degraded and 10 being the most intact or high quality RNA. Generally, it is 
recommended to use samples that have RIN greater than 8.0 for microarray. Since 
RNA quality is crucial for achieving success in microarray experiments, only samples 
that have RIN greater than 9.0 were processed for downstream experiments. 
9.2.2. Microarray analysis and qPCR validation 
Despite optimized RNA isolation protocol from FACS-purified germ cells, the 
amount of RNA obtained is much less than 500 ng, which is the recommended 
starting RNA quantity for the in vitro transcription (IVT) kit from Ambion. Therefore, 
I have used the Ovation RNA amplification strategy followed by in vitro biotin-
labeling (Illustration 4). Microarray was performed on E11.5, E13.5 and E15.5 germ 
cells, and E13.5 GFP-negative non-germ cells from the gonad were used as negative 
control. Hierarchical clustering of the microarray samples using all (> 45 200) probes 
reveals that E11.5, E13.5 and E15.5 germ cells cluster together and differ from the 
non-germ cell cluster (Figure 6). All biological replicates (harvested and purified on 
independent days) of the same time point cluster together, rendering confidence to the  
  
 
Illustration 4: Microarray strategy using small quantities of RNA. 10 ng of RNA 
isolated from FACS purified germ cells was amplified using the OVATION RNA 
amplification V2 kit (NuGEN), after which the cDNA was biotin-labeled and 












Figure 6: Hierarchical clustering of microarray samples. Biological triplicate data 
(a,b and c) are shown for E11.5, E13.5 and E15.5 germ cells while biological 
duplicate data (a and b) are shown for Non-germ cells as control. The x-axis 






data quality. Notably, the clustering result also suggests that E13.5 germ cells are 
more closely related to E11.5 germ cells as compared to E15.5 germ cells, at least on 
a transcriptome level. 
Closer inspection of specific transcripts reveals that pluripotency-associated markers 
such as Sox2, Nanog and Prdm14 are downregulated from E11.5 to E15.5 (Figure 7a). 
On the other hand, Pou5f1 is only marginally downregulated and still remains 
enriched in E15.5 germ cells compared to non-germ cells. Post-migratory germ cell 
markers Dazl and Ddx4 are also upregulated by E13.5. While Dazl is already highly 
expressed at E11.5, it peaks in expression at E13.5. Ddx4 shows a consistent 
upregulation from E11.5 to E13.5 and its high expression is maintained at E15.5. 
Realtime quantitative PCR (qPCR) was performed to validate the microarray data 
(Figure 7b) and shows similar trends.  
It has previously been shown that the potential of in vivo- derived germ cells to be 
converted to pluripotent EGC declines from E8.5 to E12.5 (Labosky et al., 1994). One 
possible explanation is the downregulation of pluripotency-associated genes in post-
migratory germ cells when they arrive at the developing gonad. By comparing 
microarray data of mESCs (v6.4 mESC and R1 mESC) and MEFs (Pou5f1-GFP MEF 
and Actin-GFP MEF) (Heng et al., 2010), an ESC-enriched gene list was generated to 
include the top 100 genes that are at least 5-fold upregulated in ESCs compared to 
MEFs (q-value < 0.01). A microarray heatmap was then plotted to illustrate the 
transcriptional changes of these ESC-enriched genes in germ cells (Figure 8). Two-
class unpaired T-test was performed to compare germ cells of each time point to non- 
 Figure 7: qPCR validation of microarray data. (a) Microarray heatmaps (log-
transformed, mean-centered) showing biological triplicate data (a,b and c) for E11.5, 
E13.5 and E15.5 germ cells and biological duplicate data (a and b) for Non-germ cells 
(Non-GC) as control. (b) qPCR validation for selected pluripotency and germ cell 
markers. Data represents the mean ± s.e.m. of three biological replicates (n = 3). 
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 Figure 8: Microarray heatmap illustrating expression changes of top 100 ESC-
enriched genes. Data was log-transformed and mean-centered prior to plotting the 
heatmap. Biological triplicate data (a,b and c) are shown for E11.5, E13.5 and E15.5 
germ cells while biological duplicate data (a and b) are shown for Non-germ cells 





germ cells. Using a cut-off of fold change > 1.5 and q-value < 0.01, 46% of the ESC-
enriched genes are upregulated in E11.5 germ cells, 48% in E13.5 germ cells and 37% 
in E15.5 germ cells. In combination, 74% of ESC-enriched genes are more highly 
expressed in germ cells (E11.5, E13.5 and/or E15.5) than non-germ cells.  
This group of genes that are upregulated in both ESC and germ cells is enriched for 
Gene Ontology (GO) categories such as transcription factor (p-value = 5.1 x 10-5), 
stem cell maintenance (p-value = 8.0 x 10-7) and transforming growth factor-beta 
(TGFβ)- related genes (p-value = 4.9 x 10-3). These genes also show variable patterns 
of expression changes as germ cells progress from E11.5 to E15.5 (Figure 8). As 
expected, many ESC-associated genes are downregulated during this period (Figure 
9a). These downregulated ESC-associated genes such as Pou5f1, Sox2, Nanog, Esrrb, 
Dppa2, Dppa4, Klf2, Klf5, Zic3, Rfx2, Utf1, Nr5a2, Lin28, Cdh1 and Tcfcp2l1 have 
been shown to be important in the maintenance of pluripotency in ESCs or 
reacquisition of pluripotency during somatic cell reprogramming (Feng et al., 2009a; 
Jiang et al., 2008; Kooistra et al., 2010; Lim et al., 2007; Pardo et al., 2010; Redmer et 
al., 2011; Takahashi and Yamanaka, 2006; van den Berg et al., 2010; Yu et al., 2007; 
Zhang et al., 2006). Curiously, genes related to the TGFβ signaling pathway, Gdf3, 
Lefty1 and Nodal, show elevated expression in E13.5 germ cells followed by 
downregulation at E15.5 (Figure 9b). This may suggest an importance of TGFβ 
signaling pathway in E13.5 germ cells, which is consistent with a previous report that 
TGFβ signaling pathway negatively regulates fetal and postnatal germ cell 
proliferation (Moreno et al., 2010). On the other hand, some ESC-enriched genes are 




Figure 9: Microarray heatmaps of downregulated and upregulated ESC-
enriched genes. (a) Pluripotency-associated genes (b) Tgfβ signaling pathway 
members (c) Dnmt3 and Dnmt3l. Biological triplicate data (a,b and c) are shown for 
E11.5, E13.5 and E15.5 germ cells while biological duplicate data (a and b) are shown 






may be crucial for male germ cell imprinting (Bourc'his et al., 2001; Hata et al., 
2002). 
To gain further insight into major biological changes that occur from E11.5 to E15.5, 
genes that exhibit > 1.5-fold downregulation from E11.5 to E15.5, and are > 1.5-fold 
enriched in E11.5 compared to non-germ cells were further analyzed. Enriched GO 
annotation clusters for biological processes include cell cycle (p-value = 7.71 x 10-12), 
DNA packaging (p-value = 5.59 x 10-5), stem cell maintenance (p-value = 4.90 x 10-
4), RNA splicing (p-value = 3.21 x 10-4) and germ cell migration/ apoptosis (p-value = 
4.76 x 10-3) (Figure 10a). Transcription factor is also enriched as GO category for 
molecular function (p-value = 6.87 x 10-3). The downregulation of cell cycle genes 
such as Ccnb1, Cdca3 and c-Myb indicate reduced mitotic entry after E13.5 (Ayad et 
al., 2003; Nakata et al., 2007). DNA packaging genes include histone genes 
(Hist1h2af, Hist1h2ad, Hist1h1a, Hist2h3c1, Hist2h2ac, Hist1h2bj, Hist1h2ai, 
Hist1h2ah, Hist1h3e, Hist1h2ao) and HELLS, which is a member of the SNF2 family 
of chromatin remodeling proteins shown to modulate DNA methylation (Tao et al., 
2011), spermatogonial proliferation and meiotic progression in germ cells (De La 
Fuente et al., 2006; Zeng et al., 2011). Therefore, the microarray data suggests that 
molecular changes that occur involve multiple levels of regulation such as 
epigenetics, transcriptional control and even post-transcriptional splicing. Visual 
inspection of the microarray heatmaps plotted for downregulated genes also reveals 
that majority of stem cell maintenance genes and cell cycle genes are transcriptionally 
downregulated after E13.5 (Figure 9a, 11b-c). On the other hand, germ cell migration 
genes and apoptosis-related genes are downregulated earlier and more gradually from 
E11.5 to E15.5 (Figure 11a).  
  
 
Figure 10: Enriched GO biological process categories for upregulated and 
downregulated genes. Significant GO categories (p < 0.05) for genes that are (a) 
downregulated from E11.5 to E15.5, (b) upregulated from E11.5 to E13.5 or (c) 
upregulated from E11.5 to E15.5. 
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Figure 11: Microarray heatmaps of downregulated genes (from E11.5 to E15.5) 
related to (a) germ cell migration and programmed cell death (b) stem cell 
maintenance and (c) cell cycle. Biological triplicate data (a,b and c) are shown for 
E11.5, E13.5 and E15.5 germ cells while biological duplicate data (a and b) are shown 





Upregulated genes were similarly analyzed. Enriched GO categories for genes that are 
> 1.5-fold upregulated from E11.5 to E13.5, and at least 1.5-fold enriched in E13.5 
compared to non-germ cells were examined (Figure 10b). The top significant GO 
category for biological process is related to regulation of transcription (p-value = 6.94 
x 10-5) (Figure 12a), which is defined as “any process that modulates the frequency, 
rate or extent of cellular DNA-dependent transcription”. Transcription factors also 
form an enriched GO category for molecular function (p-value = 1.05 x 10-3). One 
notable upregulated transcription factor is Cdkn2a, also known as p16INK4A, which 
arrests cell cycle in G1 phase by its interaction with CDK4. Importantly, Cdkn2a 
poses a barrier to iPS reprogramming, and its inhibition improves reprogramming 
efficiency (Li et al., 2009). The second most significant GO category for biological 
process is chromosome organization (p-value = 4.04 x 10-4) (Figure 12b) which 
includes the chromatin remodeling gene Arid4a with functions in genomic imprinting 
(Wu et al., 2006a) and cell cycle arrest (Lai et al., 2001), NuRD complex subunit 
Rbbp7, as well as H3K4 methyltransferases Setd7 and MLL3.   
Generally, genes that are upregulated at E13.5 may be clustered into two groups 
(Figure 12). Group 1 includes genes that are upregulated at E13.5 and maintained at 
E15.5, while group 2 includes genes that are upregulated transiently at E13.5. Group 1 
genes, such as Cdkn2a, may explain why E13.5 germ cells cannot be reverted to 
pluripotent EGC, despite the observation that many of the pluripotency-associated 
genes have not been fully repressed. Group 2 genes, on the other hand, may be 
required transiently for the germ cells to make a switch to commit towards germ cell 
differentiation. More experiments would be required to test these hypotheses. 
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Figure 12: Microarray heatmaps of upregulated genes (from E11.5 to E13.5) 
related to (a) regulation of transcription and (b) chromosome organization. 
Biological triplicate data (a,b and c) are shown for E11.5, E13.5 and E15.5 germ cells 




Lastly, genes that are > 1.5-fold upregulated from E11.5 to E15.5, and at least 1.5-
fold enriched in E15.5 compared to non-GC are enriched for spermatogenesis (p-
value = 2.98 x 10-5) and reproductive developmental process (p-value = 6.18 x 10-3) 
(Figure 10c). These genes are largely upregulated later between E13.5 to E15.5 
(Figure 13). One of the earliest upregulated spermatogenesis-related genes is Nanos2 
which is upregulated more than 9-fold at E13.5. Nanos2 encodes for the RNA-binding 
protein that has been previously shown to prevent meiosis and activate the male germ 
cell differentiation program (Suzuki and Saga, 2008).  
In summary, the microarray data analyses suggest that germ cells undergo major 
transcriptional changes between E11.5 to E15.5, especially after E13.5. Many ESC-
enriched genes are also enriched in germ cells compared to non-germ cells, including 
stem cell maintenance genes that are largely downregulated between E13.5 to E15.5. 
Most of the genes that promote mitotic progression are also transcriptionally 
repressed after E13.5. Contrary to repression of the downregulated genes, induction of 
some genes occurs earlier between E11.5 to E13.5. Notable examples include Cdkn2a 
and Nanos2 that are likely to reduce germ cell “pluripotential” and promote 
expression of other germ cell differentiation genes (Illustration 5). Lastly, majority of 
genes involved in spermatogenesis are only upregulated later at E15.5. In addition, 
GO analyses suggest that these molecular changes involve both transcription factors 
and chromosomal organization, hence providing motivation to study epigenetic 
properties of germ cells during this dynamic period. Moreover, germ cells at 13.5 
d.p.c. are undergoing a transitional phase and provide a good timepoint to study 






Figure 13: Microarray heatmap of upregulated genes (from E11.5 to E15.5) 
related to spermatogenesis and reproductive processes. Biological triplicate data 
(a,b and c) are shown for E11.5, E13.5 and E15.5 germ cells while biological 










Illustration 5: Developmental progression of germ cells from E11.5 to E15.5. 
From E11.5 to E15.5, male germ cells lose pluripotential and the ability to revert to 







9.3. Small-scale ChIP on purified germ cells 
9.3.1. Optimization of small-scale ChIP using mESCs 
Before embarking on the actual germ cell ChIP, I first optimized the small-scale ChIP 
procedures using mESCs that are abundantly available from cell cultures. Since the 
ultimate goal is to generate genome-wide ChIP-Seq libraries from small numbers of 
FACS-purified cells, an amplification step is essential for providing sufficient DNA 
for library preparations. Our laboratory (Dr Muratani Masafumi) has established a 
small-scale ChIP procedure (Illustration 6), whereby de-crosslinked ChIP DNA is 
subjected to Whole Genome Amplification (WGA) followed by two rounds of BpmI 
restriction digestion to excise the PCR adaptors prior to ChIP-Seq library preparation.  
Experiments were conducted to examine the effects of WGA on ChIP. A normal-scale 
ChIP was performed against H3K4me3 using mESC chromatin, and small amounts of 
de-crosslinked DNA (50 pg, 250 pg and 500 pg) as determined by Picogreen 
quantitation were subjected to 15 cycles of WGA. As compared to control regions, 
ChIP enrichment was detected at the Pou5f1 promoter and known bivalent promoters 
such as Zfpm2 and Dlx1 both before and after 15 cycles of WGA (Figure 14a,b). The 
pattern of relative enrichment across different tested regions appears unaffected by 
WGA, but a reduction in fold enrichment was observed when starting amount of DNA 
is reduced to 50 pg. Nevertheless, 15 cycles of WGA from 50 pg of de-crosslinked 
ChIP DNA provides a yield of about 500 ng, indicating an amplification of 





Illustration 6: Experimental workflow of germ cell ChIP-Seq. Germ cells were 
FACS-purified based on Pou5f1-GFP expression. Following ChIP, the de-crosslinked 
immunoprecipitated DNA was amplified by WGA. Amplification adaptors were 





Figure 14: Similarity of H3K4me3 ChIP signals before and after WGA 
amplification. (a) qPCR results of normal-scale H3K4me3 ChIP performed on E14 
mESC (a) without amplification and (b) after 15 cycles of WGA amplification from 
50 pg, 250 pg or 500 pg of ChIP DNA. (c) DNA yield after 15 cycles of WGA 




with 15 WGA cycles, as DNA yield continues to increase with amount of input DNA 
(Figure 14c). ChIP-Seq libraries were generated using the samples that were WGA-
amplified from 50 pg of de-crosslinked H3K4me3 ChIP DNA. The WGA technical 
duplicates (WGA1 and WGA2) show similar peaks to each other and the non-
amplified library (Figure 15a). On a genome-wide level, WGA1 and WGA2 are 
highly correlated (r = 0.977) and have a peak overlap of 95.6%. When WGA1 or 
WGA2 is compared to the non-WGA library, correlation remains high (r = 0.898 and 
0.896) with peak overlap of 86.4% and 86.1% respectively (Figure 15b). In summary, 
WGA provides an attractive amplification tool for small-scale ChIP. 
Next, I proceeded to perform the small-scale ChIP procedures on small numbers of 
mESCs. Compared to a typical ChIP, procedures have been fine-tuned to reduce 
material loss and background levels. Small-scale H3K4me3 ChIP gave good fold 
enrichments at tested sites when 100,000 mESCs were used without WGA 
amplification (Figure 16a). It is difficult to examine ChIP enrichment by qPCR if the 
starting cell numbers were reduced to below 100,000 due to inherent qPCR detection 
limitations. Therefore, all subsequent experiments included the WGA step prior to 
qPCR. ChIP enrichment could be achieved from as little as 10,000 mESCs, but the 
fold enrichment decreased as cell numbers were reduced from 100,000 to 10,000 
(Figure 16b). To achieve good quality ChIP-Seq, it is always better to begin with 
larger cell numbers, especially given the consideration that H3K4me3 antibody 
provides one of the best enrichments among the tested antibodies. 
 Figure 15: Genome-wide comparisons of H3K4me3 ChIP before and after WGA 
amplification. (a) UCSC browser view of H3K4me3 ChIP-Seq signals. (b) 
Scatterplot of H3K4me3 ChIP-Seq signals and Venn diagram illustrating overlap of 




          
Figure 16: Small-scale ChIP could be performed on fewer numbers of cells. (a) 
qPCR results of small-scale H3K4me3 ChIP performed on 100,000 E14 mESC 
without WGA amplification. (b) qPCR results of small-scale H3K4me3 ChIP 
performed on  10,000, 25,000 and 100,000 E14 mESC, after 15-18 cycles of WGA 
amplification. Pou5f1 DE and Pou5f1 Pro refer to the distal enhancer and proximal 
promoter of the Pou5f1 gene respectively. Data represents the mean ± s.e.m. of three 





9.3.2. Germ cell ChIP-Seq led to identification of active regulatory 
elements 
GFP-positive germ cells were purified, fixed and frozen at -80°C until sufficient cell 
numbers are achieved (Illustration 6, Step 1). Cells were then pooled so that 
approximately 50,000 to 100,000 germ cells were used for each ChIP experiment. 
ChIP-Seq libraries were generated in duplicates for H3K4me3, H3K27me3, H3K27ac 
and H2BK20ac after enrichment was validated by qPCR (Figure 17).  
Reproducibility was examined by plotting tag counts across 1-kb bins. The ChIP 
duplicates for H3K4me3 and H3K27me are highly correlated (r = 0.87 and 0.85) 
(Figure 18a), and visual inspection of signals in the UCSC browser also shows similar 
peaks at gene promoters in the H3K4me3 duplicates (Figure 18b). However, the 
duplicates for H3K27ac and H2BK20ac are less well-correlated (r = 0.74 and 0.75). 
Stringent criteria were thus set for downstream analyses: (1) peak detection using p-
value < 0.05 and (2) only peaks that overlap in biological duplicates are used. 
To investigate how the occurrence of histone marks at promoter regions correlate with 
expression levels, genes were first grouped into 3 categories based on microarray 
expression: (1) high = above 80th percentile, (2) medium = 40-60th percentile and (3) 
low = below 30th percentile. The histone ChIP-Seq signals were plotted for each of 
these 3 categories, spanning 4 kb around known transcriptional start sites (TSS) 
(Figure 19). H3K4me3 and H3K27ac positively correlate with expression levels, 
while H3K27me3 show an inverse relationship. This observation supports the notion 
that H3K4me3 and H3K27ac mark active gene promoters and H3K27me3 mark 




Figure 17: Histone ChIP-qPCR results of E13.5 male germ cells. Data represents 
the mean ± s.e.m. of two independent experiments (n = 2). Pou5f1 DE and Pou5f1 Pro 




 Figure 18: Reproducibility of small-scale ChIP-Seq. (a) Scatterplots of tag counts 
across 1-kb bins for ChIP duplicates of H3K4me3, H3K27me3, H3K27ac and 
H2BK20ac. (b) UCSC browser view illustrating ChIP-Seq signal profile for ChIP 
duplicates of H3K4me3 and controls. 
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Figure 19: Relationship between histone mark occurrence and expression levels. 
Plotting the average ChIP-Seq profiles of H3K4me3, H3K27ac and H3K27me3 for 
genes with high (red), medium (green) and low (blue) expression. y-axis = fold 





of H3K27me3, and the magnitude of difference among the different levels of 
expression was not as striking as H3K4me3 and H3K27ac. H3K27me3 may not be a 
good indicator of expression since bivalently marked regions are expressed at basal 
levels (Berstein et al., 2006). This could also signify that other repressive histone 
marks and perhaps DNA methylation may play more critical roles than H3K27me3 in 
suppressing gene expression. A dip was also observed at the TSS, a phenomenon 
which may be attributed to nucleosome depletion at transcription factor binding sites.  
The ChIP-Seq peaks were viewed on the UCSC browser at specific genomic locations 
(Figure 20). Promoters are generally marked by H3K4me3 near the TSS. 
Pluripotency-associated genes such as Tcl1, Zic3 and Klf2 as well as germ cell-
associated genes such as Bbx and Dazl exhibit active marks of H3K27ac and 
H2BK20ac but not H3K27me3. On the other hand, known bivalent genes such as Dlx 
and Hox genes are marked by both H3K4me3 and H3K27me3, but not H3K27ac and 
H2BK20ac. Interestingly, the Esrrb promoter region is already marked by bivalent 
markers although its transcript is expressed in E13.5 germ cells. However, it remains 
unclear if the Esrrb promoter is simultaneously marked by both H3K4me3 and 
H3K27me3 or this result represents a heterogenous cell population with the Esrrb 
promoter being marked by either histone modification. 
Next, we wanted to focus on promoters that are specifically activated in germ cells. 
Germ cell-specific active promoters, marked by both H3K4me3 and H3K27ac, were 
identified by comparison with other cell types such as liver, ProB, neural progenitor 
cells (NPC) and mESCs (Figure 21a) (Creyghton et al., 2010). Genomic Regions 
Enrichment of Annotations Tool (GREAT) analysis was performed using whole  
  
 
Figure 20: UCSC browser view of active and bivalent regions.  
Active promoters are marked by H3K4me3 and H3K27ac (and H2BK20ac) whereas 







Figure 21: Discovery of E13.5 germ cell-secific active promoters with biological 
relevance. (a) Plot of H3K4me3 and H3K27ac ChIP-Seq signals, which are hallmarks 
indicative of active promoters. Germ cell-specific promoters are shown below the 
dotted line. (b) Enriched GO categories for mouse phenotype for genes located near 
E13.5 germ cell-specific active promoters (GREAT analysis: single nearest gene 





mouse genome as background and taking positives as the nearest gene within 30 kb of 
the germ cell-specific promoters. By setting a false discovery rate (FDR) cut off as 
0.05, genes located near germ cell-specific active promoters were found to be highly 
enriched (q-value < 9E-09) for mouse phenotypes related to reproduction and male 
fertility (Figure 21b).  
Besides promoters, enhancers are also regulatory elements that are tightly regulated 
during development (Heintzman et al., 2009; Visel et al., 2009a).  A total of 3494 
active enhancers were identified based on H3K27ac and H2BK20ac peaks in both 
biological replicates and were not lying on any known gene promoter or H3K4me3 
peak of any replicate. To validate these germ cell enhancers, 15 genomic fragments 
with lengths ranging from 500 bp to 1.7 kb were cloned downstream of the luciferase 
gene that is driven by the Pou5f1 minimal promoter (Table 1; Figure 23a). These 
enhancer regions could be lying within a gene body, near a TSS or far from any 
known genes (Figure 22). Four random genomic regions were also included as 
controls. Luciferase assay was then performed in an embryonic germ cell line, Tg2-
EGC (Labosky et al., 1994) and 293T to check for enhancer activities. Eleven out of 
15 tested regions (73.3%), but none of the 4 control regions, had more than 2-fold 
luciferase activity relative to the minimal promoter-only control (p < 0.05) (Figure 
23b-c; Table 2-3). The enhancer property of these 11 regions was also specific to 
Tg2-EGC since luciferase activity was not detected in transfected 293T control cell 
type.  
Given that germ cells resemble ESCs in several aspects such as expression of many 
pluripotency regulators, and early germ cells can be converted to pluripotent EGCs by  




 Figure 22: UCSC browser view of tested enhancer regions. The red horizontal bar 
indicates position of the enhancer region. 
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 Figure 23: Luciferase assay validation of enhancers in EGC and 293T control. (a) 
Schematic of modified pGL3 vector that contains a 500-bp Pou5f1 minimal promoter 
(Pro). The tested enhancer regions were cloned downstream of the firefly luciferase 
reporter gene. (b) Luciferase activity is expressed as a ratio relative to vector 
containing the minimal promoter only (Minimal Pro). The 2.3-kb Pou5f1 promoter 
(Pou5f1 Pro) which includes both distal and proximal enhancer serves as a positive 
control. Data represents the mean ± s.e.m. of five independent experiments (n = 5). 
Asterisks mark regions with at least 2-fold relative luciferase activity (Student’s T-
test, One-tailed p-value < 0.05). (c) Log2-transformed version of (b). 
71 
 













altering culture conditions alone, one attractive hypothesis is that germ cells may also 
be epigenetically more similar to ESCs. Out of 3494 active enhancers in E13.5 male 
germ cells, 19.6% overlap with active enhancers in mESC (Figure 24). The overlap of 
active enhancers with ESC is 11.6%, 12.4% and 19% for liver, ProB                        
and NPC respectively. By filtering active enhancers in liver, ProB, ESC and NPC, 
germ cell-specific enhancers were discovered (Figure 25a). GREAT analysis was 
performed using whole mouse genome as background and positives as the nearest 
gene within 30 kb of the germ cell-specific enhancers. Taking FDR < 0.05 and q-
value < 0.001, genes neighboring germ cell-specific enhancers are enriched for mouse 
phenotypes such as gametogenesis, reproduction and testicular abnormalities (Figure 
25b), suggesting biological relevance of the identified germ cell enhancers. 
In summary, our modified small-scale ChIP protocol enabled the genome-wide 
mapping of histone modifications from small numbers of purified germ cells, from 
which invaluable information could be retrieved. The combinatorial occurrences of 
histone modifications reveal the nature (promoter vs enhancer) and status (active vs 
inactive/ poised) of regulatory elements, and can be useful for predicting gene 
expression. In addition, by comparison with publicly available ChIP-Seq data for 
other cell types (Creyghton et al., 2010), germ cell-specific enhancers with implicated 
biological relevance were identified. Given that enhancers serve as important 




     
Figure 24: Overlap of cell type-specific enhancers with ESC enhancers.  
The overlap of E13.5 germ cell-specific enhancers, Liver-specific enhancers, ProB-
specific enhancers and NPC-specific enhancers with ESC enhancers is expressed as a 
percentage of the respective cell type-specific enhancers. Data from other somatic cell 
types, besides E13.5 germ cells, is derived from previously published data (Creyghton 








Figure 25: Discovery of E13.5 germ cell-specific enhancers with biological 
relevance (a) Plot of H3K27ac and H2BK20ac ChIP-Seq signals, which are 
hallmarks indicative of active enhancers. Germ cell-specific enhancers are shown 
below the dotted line. (b) Enriched GO categories for mouse phenotype for genes 
located near E13.5 germ cell-specific enhancers. (GREAT analysis: single nearest 





9.4. Discovery of germ cell regulators 
9.4.1. Potential regulators of germ cell differentiation and 
“pluripotential” 
To discover enriched motifs found at germ cell enhancers, the Multiple EM for Motif 
Elicitation (MEME) program was applied. Our de novo motif search led to the 
discovery of a 15-bp palindromic motif (Figure 26) that does not match any known 
transcription factor motif. It is possible that the transcription factor that binds this 
motif at germ cell enhancers is yet to be discovered. Alternatively, such as 
transcription factor may have different binding preference in germ cells compared to 
the motif that is published in the MEME database. We then attempted to search for 
potential germ cell regulators by finding comparative enrichment of known 
transcription factor motifs in the cell type-specific enhancers (Table 4). Notably, the 
top enriched motifs that emerged from our analysis have known functions for the 
respective cell types. For example, HNF and CEBPA for liver enhancers (Cereghini, 
1996), ETS family motifs for ProB enhancers (Maroulakou and Bowe, 2000) and AP2 
for NPC enhancers (Schmidt et al., 2011). Similarly, E2F, Klf4, Esrrb and Nr5a2 
motifs were among the top motifs enriched at ESC enhancers. Motifs that were more 
enriched at E13.5 male germ cell enhancers include FoxP1 and Dmrt. Interestingly, 
FoxP1 is a member of the forkhead box (FOX) family of transcription factors which 
play important roles in regulating cell type-specific transcriptional programs of 
diverse cell types (Hannenhalli and Kaestner, 2009). An ESC-specific isoform of 
FoxP1 was recently shown to participate in iPSC reprogramming by suppressing the 
expression of differentiation genes and stimulating pluripotency-associated genes  
  
Figure 26: De novo motif discovery using germ cell enhancers.  










such as Pou5f1, Nanog, Nr5a2 and Gdf3 (Gabut et al., 2011). Members of the 
doublesex and mab-3-related transcription factor (Dmrt) family are known for their 
conserved functions in sex determination (Hong et al., 2007). Strikingly, Dmrt motifs 
were also among the top hits when we searched for transcription factors whose motif 
is anti-correlated with H3K27me3 at ESC-bivalent sites (Figure 27). This result 
suggests that Dmrt family members may be important in regulating genes that are 
poised in ESCs but become activated in germ cells. 
To find transcription factors that are crucial in regulating transcriptional changes and 
potentially play a role in mediating developmental transition of germ cells during the 
11.5 to 15.5 d.p.c period, motif enrichment analysis was also applied to regulatory 
elements located near differentially expressed genes. We first clustered genes based 
on microarray expression, and found a set of genes whose expression is 
downregulated in E15.5 germ cells as compared to E11.5 germ cells (Class 1), and 
another cluster of genes whose expression is upregulated in E15.5 germ cells in 
comparison to E11.5 germ cells (Class 2) (Figure 28a). For both classes of genes, we 
selected H3K27ac and H2BK20ac peaks which were located within 10 kb of their 
transcriptional start site. Upon motif enrichment analysis, we found that peaks located 
around Class 2 genes had higher occurrence rate for transcription factors such as 
Egr1, Egr4, Znf219 and MovoB (Figure 28c), some of which are known to be 
important for male germ cell differentiation (Hogarth et al., 2010; Tourtellotte et al., 
1999; Tourtellotte et al., 2000). Egr1, Egr4 and Znf219 are upregulated from E11.5 to 
E15.5, although the upregulation of Znf219 is modest (Figure 29b); MovoB, also 
known as Ovol2, is expressed at slightly higher levels at E13.5 but is quickly 
downregulated by E15.5 (Figure 29b). Interestingly, Znf219 is also a protein 
  
Figure 27: Motifs found to be anti-correlated to H3K27me3.  
Using ESC-bivalent regions (i.e. regions marked by both H3K4me3 and H3K27me3 
in ESC), the correlation of motif enrichment to occurrence of H3K27me3 in E13.5 
germ cells was computed. The negative correlation (anti-correlation), as indicated by 
the x-axis of the plot, of Dmrt motifs to H3K27me3 in E13.5 germ cells suggests that 






Figure 28: Motif analysis of differentially expressed genes. (a) Microarray 
heatmaps of Class 1 and Class 2 genes. (b) Enriched motifs for Class 1 and Class 2 
genes. (c) Transcription factor binding at cell type-specific enhancers. The 
frequencies of transcription factor binding at cell type-specific enhancers are 
expressed as fold relative to ProB’s frequency. Asterisk indicates significant (* p < 
0.05; ** p < 0.005) enrichment of binding at germ cell-specific enhancers compared 





Figure 29: Microarray heatmaps of transcription factors with motifs enriched at 






interaction partner of Oct4 in mESCs (Pardo et al., 2010; van den Berg et al., 2010; 
Wang et al., 2006), and associates with Sox9 to regulate chondrocyte differentiation 
(Takigawa et al., 2010). Incidentally, Sox9 is a central male sex-determining factor 
(da Silva et al., 1996; Kocer et al., 2009), which is highly expressed in non-germ cells 
and upregulated in E15.5 germ cells (Figure 29b). As such, it would be interesting to 
further examine whether Znf219 also interacts with Sox9 in the gonad, and if Znf219 
is important for germ cell differentiation. Importantly, the peaks located near Class 1 
genes had higher frequency of motifs for transcription factors that have been 
functionally associated to ESC maintenance, iPSC reprogramming or cell 
proliferation  (Figure 28b), as exemplified by Znf143 (Chen et al., 2008a), Tcf3 (Tam 
et al., 2008; Wray et al., 2011; Yi et al., 2011; Yi et al., 2008), Nr5a2/Nr5a1 (Guo and 
Smith, 2010; Heng et al., 2010), Myc (Cartwright et al., 2005; Lin et al., 2009; Singh 
and Dalton, 2009; Smith et al., 2010) and E2F1 (Chen et al., 2008b; Chong et al., 
2009). Microarray data also reveals that these factors themselves are downregulated 
by E15.5 (Figure 29a). Therefore, shutting down the pluripotency-related network 
seems to be a major theme for germ cells during the E11.5 to E15.5 d.p.c. period.  
The similarity between the motifs of Nr5a1 and Nr5a2 suggests that either one of 
them could be binding the H3K27ac/ H2BK20ac-marked sites to maintain 
“pluripotential” of early germ cells. To corroborate the above analysis, we compared 
the overlap of enhancers from different cell types with transcription factor ChIP-Seq 
peaks from mESC (Chen et al., 2008b). Sox2 motif is enriched at both E13.5 germ 
cell and NPC enhancers (Figure 28c). Enrichment of Sox2 binding at NPC enhancers 
may not be surprising given that both Sox2 has been implicated in neural 
differentiation (Ferri et al., 2004). Interestingly, Nanog and Nr5a2 ChIP-Seq peaks  
Table 5: Transcription factor binding (fold) at cell type-specific enhancers.    
The frequencies of transcription factor ChIP-Seq peaks at cell type-specific enhancers 
of E13.5 male germ cells (MGC), NPC and ProB are expressed as a fold relative to 




Table 6: Two proportion p-values and test statistics for transcription factor 
binding at cell type-specific enhancers.   
The p-value and Z-score statistics to test for significant difference between the 
transcription factor binding frequencies at E13.5 male germ cell (MGC) compared to 






were more enriched at E13.5 germ cell enhancers in comparison to enhancers of NPC 
and ProB (p-value < 0.05) (Figure 28c; Table 5-6). Nanog is expressed in migratory 
and mitotic post-migratory germ cells (Yamaguchi et al., 2005) and has been reported 
to be important for developmental progression of male germ cells beyond E11.5 
(Chambers et al., 2007). Taken together, this result suggests that Nr5a2 may 
potentially be important for germ cell regulation. 
9.4.2. Dmrt1 
Members of the Dmrt family of transcription factors persistently emerge in our search 
for germ cell regulators. Highly related to the doublesex gene of Drosophila and the 
mab-3 gene of Caenorhabditis elegans, Dmrt family members are characterized by the 
conserved DM (dsx and mab-3) DNA binding domains and roles in sexual 
differentiation (Hong et al., 2007). Among the eight Dmrt members in mammals, 
Dmrt1 is the member that is best known for its gonadal-specific expression and 
functions in both sex determination as well as male germ cell differentiation in a 
myriad of species including mouse, fish, birds and amphibians (Hong et al., 2007; 
Raymond et al., 2000). In humans, deletion of a region on chromosome 9 where 
Dmrt1, Dmrt2 and Dmrt3 are located causes 46, XY gonadal dysgenesis and sex 
reversal (Raymond et al., 1999). Other than Dmrt1, several other family members 
such as Dmrt3, Dmrt4, Dmrt7 and Dmrt8 were previously reported to be expressed in 
the embryonic gonad (Kim et al., 2003; Veith et al., 2006). However, it is unclear if 
all of these factors are expressed in the germ cells or the gonadal somatic cells such as 
Sertoli or Leydig cells. 
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Microarray data, validated by qPCR, reveals that Dmrt1 and Dmrtc1c (also known as 
Dmrt8) are the only two family members that are more highly expressed in E13.5 
germ cells (Figure 30a,b). Curiously, their transient expression at E13.5 decreased to 
non-germ cell levels by E15.5. Another family member, Dmrt7, is gradually 
upregulated and is expressed significantly more than non-germ cells on 15.5 d.p.c. 
Dmrt7 is required for male but not female gametogenesis given that homozygous 
knockout males are infertile in contrast to fertile females (Kim et al., 2007b). 
However, Dmrt7 is only required at a later stage of gametogensis as Dmrt7 mutant 
germ cells arrest postnatally at the pachytene stage of meiosis (Kim et al., 2007b). On 
the other hand, Dmrt8 is unique in that it does not have the DM domain that the other 
seven family members possess (Veith et al., 2006), and was proposed to dimerize with 
other Dmrt family members to act as either co-regulator or dominant-negative 
regulator (Veith et al., 2006). Taking both germ cell expression and literature into 
consideration, it is likely that Dmrt1 is the family member that binds to active 
enhancers in E13.5 male germ cells. 
Previous studies have shown that Dmrt1 expression is dynamically regulated in male 
and female gonads in a sex-dependent manner. In the embryo, Dmrt1 is expressed in 
both male and female germ cells with a peak in expression level at E13.5 followed by 
downregulation at E15.5 (Lei et al., 2007). However, Dmrt1 is increasingly expressed 
in male but not female gonadal somatic cells from E12.5 onwards, and such sexually 
dimorphic expression is maintained after birth when Dmrt1 is expressed in the testis 
but not the ovary (Lei et al., 2007). Interestingly, Dmrt1 is upregulated in germ cells 
again on 0.5 days post partum (d.p.p) in the testis only (Lei et al., 2007). Given that 
the expression pattern of Dmrt1 in germ cells corresponds to the proliferative stages 
         
Figure 30: Expression of Dmrt1 and Dmrt family members in germ cells.  (a) 
Microarray heatmaps and (b) qPCR results for Dmrt family members in male germ 
cells (MGC: E13.5 male germ cells) and non-germ cells (Non-GC). Data in (b) 
represents the mean ± s.e.m. of three biological replicates (n = 3). (c) qPCR results for 
Dmrt1 using non-amplified cDNA of E13.5 male germ cells (MGC) and non-germ 
cells . Data represents the mean ± s.e.m. of two biological replicates (n = 2). (c) IHC 





of germ cells after arrival at the gonad, both before and after birth, it seems likely that 
Dmrt1 may regulate cell cycle processes. In agreement with this postulation, loss of 
Dmrt1 results in high incidence of teratoma formation due to ectopic expression of 
pluripotency gene Sox2 as well as failure of germ cells to enter mitotic arrest (Krentz 
et al., 2009). Notably, this phenotype was only observed in the 129 mouse strain, but 
not other mouse strains. In humans, Dmrt1 has also been associated with testicular 
germ cell tumor susceptibility (Kanetsky et al., 2011; Turnbull et al., 2010). Other 
than a role in mediating cell cycle arrest, Dmrt1 is important in directing appropriate 
sex differentiation. In female germ cells, Dmrt1 promotes oogenesis by activating 
Stra8 and inducing meiosis (Krentz et al., 2011). In the postnatal spermatogonia, 
Dmrt1 plays an opposite role whereby it represses Stra8 to suppress meiosis and 
activates the spermatogonial differentiation factor Sohlh1 (Matson et al., 2010). In 
sertoli cells of the testis, Dmrt1 antagonizes Foxl2 in order to maintain a sertoli 
instead of granulosa cell identity (Matson et al., 2010). Collectively, these studies 
suggest that Dmrt1 plays pivotal context-dependent roles in both germ cells and 
gonadal somatic cells, and regulates mitosis/ meiosis as well as other aspects sex 
differentiation differentially in male and female germ cells (Kim et al., 2007a). 
To confirm that Dmrt1 is expressed in the germ cells purified from the Pou5f1-GFP 
(Strain BL6 x CD1) transgenic mice, realtime qPCR was performed using non-
amplified E13.5 cDNA and indeed Dmrt1 was much enriched (260-fold) in E13.5 
male germ cells compared to non-germ cells (Figure 30c). Dmrt1 protein expression 
in E13.5 male germ cells was also verified by immunohistostaining (IHC) using rabbit 
serum that was raised against a Dmrt1 antigen (Figure 30d). Given its repression on 
pluripotency genes and inhibition of cell cycle (Krentz et al., 2009), it is surprising to 
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find that Dmrt1 is expressed in mESC, as its protein could be detected from both 
whole cell lysate (WCL) and isolated chromatin of E14 mESC by Western blot 
(Figure 31a). To investigate any potential roles of Dmrt1 in ESC, shRNA oligos were 
designed and cloned into the pLKO.1 vector. Transfected E14 mESCs exhibited 
Dmrt1 knockdown of more than 75% (Figure 31b,c). After 4 days of Dmrt1 
knockdown, either no change or a slight upregulation was observed for pluripotency 
regulators such as Pou5f1, Sox2, Nanog and Nr5a2. Dmrt1 knockdown cells also 
appeared morphologically similar to undifferentiated mESC. Therefore, Dmrt1 does 
not appear to play a role in ESC maintenance. 
The transient upregulation of Dmrt1 in male germ cells at E13.5 d.p.c. (Figure 30a,b) 
suggests that Dmrt1 may play a role in mediating the transition towards male germ 
cell differentiation. In an attempt to drive germ cell differentiation, Dmrt1 was 
overexpressed under the control of the constitutive cytomegalovirus (CMV) 
enhancer/chicken β-actin (CAG) promoter in E14 mESC. Within 3 days of 
transfection, Dmrt1-overexpressing mESC displayed increased cell death and the 
remaining attached cells appeared differentiated (Figure 32a). This phenotype is 
accompanied by downregulation of pluripotency regulators Pou5f1, Sox2 and Nanog 
(Figure 32b). Germ cell genes such as Dazl, Ddx4 and Stra8 were initially 
upregulated up to 200% of control levels after 1 day of overexpression (Figure 32c). 
However, this upregulation was soon diminished, and expression of Dazl and Stra8 
were reduced by Day 4. Probing further, I found that markers of other lineages 
especially trophectoderm (Cdx2 and Hand1) and endoderm (Gata4 and Gata6) were 
conspicuously upregulated (Figure 32d). The upregulation of other lineage markers 
may be an indirect consequence of Dmrt1’s repression of pluripotency factors. This  
              
Figure 31: Dmrt1 is expressed but not required in mESC. (a) Western blot against 
Dmrt1 in E14 mESC chromatin (Chr) or whole cell lysate (WCL). (b) Western blot, 
using anti-Dmrt1 serum, was performed on transfected E14 mESC WCL after 3 days 
of selection.  Cells were transfected with two shRNAs against Dmrt1 (KD1 and KD2) 
and Luciferase (Luci). (c) qPCR data for Dmrt1 and other pluripotency markers in 
transfected cells. Data represents the mean ± s.e.m. of two biological replicates (n = 
2). (b) Phase images of transfected cells. 
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Figure 32: Overexpression of Dmrt1 in E14 mESC caused differentiation. (a) 
Phase images of transfected cells after 3 days of selection. qPCR data for (b) Dmrt1 
and other pluripotency markers (c) germ cell markers and (d) other differentiation 
markers of primitive ectoderm (PE), trophectoderm (TE), endoderm (EN), mesoderm 
(MESO) and ectoderm (EC) in transfected cells on Day 2 and Day 4 of transfection.  
Data is normalized to empty vector control and represents the mean ± s.e.m. of three 





inability to sustain germ cell genes at the initial upregulated levels suggests that other 
critical germ cell regulators are required to induce and maintain a germ cell fate. It is 
also possible that the ectopic overexpression of Dmrt1 to more than 15-fold 
endogenous level (Figure 32a) needs to be further fine-tuned to strike a balance 
between pluripotency gene repression and germ cell gene activation, in a manner 
more akin to in vivo germ cells at 13.5 d.p.c. Alternatively, a monolayer culture 
system might not be optimal for in vitro germ cell differentiation and the culture 
media probably requires optimization in order to support germ cell survival. 
 
9.4.3. Nr5a2 
Nr5a1 and Nr5a2, also known as steroidogenic factor 1 (Sf1) and liver receptor 
homolog 1 (Lrh1) respectively, are closely related members of the Nr5a or Ftz-F1 
subfamily orphan nuclear receptors (Fayard et al., 2004). In the mouse embryo, Nr5a1 
plays important functions in steroidogenic tissues such as the adrenals and gonads, 
which are both derived from the adrenogenital primordium (AGP) (Val et al., 2003). 
Within the gonad itself, while Nr5a1 expression is not detectable in germ cells, its 
expression can be detected in the Sertoli and Leydig cells where it regulates 
steroidogenesis and hence sex differentiation (Hinshelwood et al., 2005). On the other 
hand, Nr5a2 is expressed in endodermal-derived tissues such as the intestine, liver 
and pancreas and is involved in cholesterol metabolism and steroidogenesis (Fayard et 
al., 2004). In the embryonic gonad prior to E15.5, using in situ hybridization, Nr5a2 
was reported to be expressed in germ cells and pre-Sertoli cells within the testicular 
cords (Hinshelwood et al., 2005). 
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Based on our microarray data, Nr5a2 is enriched in E11.5 and E13.5 germ cells as 
compared to non-germ cells of the gonad, but is downregulated by E15.5 (Figure 
33a). qPCR validation results indicate that Nr5a2 expression level in E13.5 male germ 
cells is 37-fold of the non-germ cell level (Figure 33b). Immunohistostaining further 
confirms that Nr5a2 is expressed in E13.5 male germ cells at the protein level (Figure 
33c). In contrast, Nr5a1 is expressed at higher levels in non-germ cells than E13.5 
male germ cells (Figure 33b). Therefore, Nr5a2 rather than Nr5a1 is the family 
member that is more specifically expressed in germ cells. 
Other than tissues of endodermal origin and the gonads, Nr5a2 is also expressed in 
the ICM and epiblast in the early embryo (Gu et al., 2005). Interestingly, Nr5a2 is 
required to maintain Oct4 expression in the epiblast but not in the ICM, and was 
found to bind directly to the proximal enhancer and promoter of the Pou5f1 gene (Gu 
et al., 2005). While Nr5a2 knockout mESCs could be established and retain 
pluripotency as assayed by in vitro differentiation and in vivo teratoma formation (Gu 
et al., 2005; Wagner et al., 2010), Oct4 expression declined more rapidly in the 
knockout cells as compared to wildtype cells under differentiation-inducing 
conditions (Gu et al., 2005). Nr5a2 was also shown to enhance reprogramming 
efficiencies and is able to replace Oct4 as a reprogramming factor (Heng et al., 2010). 
More recently, Nr5a2 was identified as an essential factor for ground state 
pluripotency, in which mESCs can be maintained in the absence of LIF and BMP 
signals (Guo and Smith, 2010). By transfecting mESCs with shRNA constructs 
targeting Nr5a2, Nr5a2 could be knockdown to less than 25% endogenous levels. 
After 3 days of selection, Nr5a2 knockdown results in downregulation of Nanog, but 
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not Pou5f1 and Sox2 (Figure 34a), and the transfected mESCs exhibited an increased 
propensity to differentiate (Figure 34b).  
Nr5a2-knockout results in embryonic lethality by 7.5 d.p.c. (Botrugno et al., 2004; Gu 
et al., 2005; Pare et al., 2004) so it is not possible to study its function in germ cells in 
vivo. To investigate if Nr5a2 has any potential functions in germ cells, I have 
undertaken an in vitro embryoid body-mediated method. The EOS reporter comprises 
three copies of the Pou5f1 distal enhancer, and is an effective reporter used in iPSC 
isolation (Hotta et al., 2009) (Figure 35a). Undifferentiated mESCs show strong GFP 
expression, which is extinguished during differentiation (Figure 35b). Embryoid 
bodies (EBs) were formed and cultured in the absence of LIF over a period of 7 days, 
and samples were sorted every 2 days (Figure 36). Over the course of 7 days, there 
was a change in both GFP fluorescence as well as cell size, which is indicated by the 
forward scatter (FSC) parameter. Within a day of EB formation, there was a shift 
from cell population 1 to cell population 2 (Figure 37). Cell population 1 consists of 
mainly GFP-positive cells that are likely residual undifferentiated mESCs. In contrast 
to cell population 1, cell population 2 comprises a larger fraction of GFP-negative 
cells and a lower average FSC that implies a smaller cell size. Beginning from Day 3 
onwards, a subset of cells within cell population 2 becomes visually distinguishable 
from the GFP-negative fraction (Figure 36). By Day 7, two subpopulations can be 
clearly seen from cell population 2. RNA was harvested from the GFP-positive sub-
population of cell population 2 and analyzed for expression of pluripotency and germ 
cell markers. Expression of Stella, Dazl, Tex19 and Stra8 show an increasing trend up 
to Day 7 while the expression of other germ cell markers Blimp1, Ddx4, Mov10l1 
increased to a peak on Day 4 followed by a decline on Day 7 (Figure 38).  
    
Figure 33:  Nr5a2 is expressed in germ cells. (a) Microarray heatmaps for Nr5a1 
and Nr5a2 in germ cells and non-germ cells. (b) qPCR results for pluripotency 
markers Pou5f1 and Sox2, and Nr5a1 and Nr5a2 in E13.5 male germ cells (MGC) and 
non-germ cells (non-GC). Data represents the mean ± s.e.m. of two biological 
replicates (n = 2). (c) IHC staining of E13.5 male gonadal sections using anti-Ddx4 




Figure 34: Nr5a2 knockdown in E14 mESC. (a) qPCR data for Nr5a2 and other 
pluripotency markers in transfected cells after 3 days of selection. Data represents the 








       
Figure 35: EOS-C(3+) reporter is specifically activated in undifferentiated 
mESC. (a) Schematic of EOS-C(3+) lentiviral vector containing a trimer of the 
Pou5f1 distal enhancer (CR4). (b) EOS-C(3+) lentiviral-infected E14 mESCs. Dotted 




 Figure 36: FACS profile of EOS-C(3+) embryoid bodies from Day 0 to Day 7. 
FACS scatterplot of dissociated cells from EBs of different timepoints (Day 0 to Day 
7). Y-axis is forward scatter (FSC) which is correlated to cell size and x-axis is GFP 







Figure 37: Cell population shift during EB differentiation.  
The percentage of total cells that fall under cell population 1 (larger average FSC) 
declines while that of cell population 2 (smaller average FSC) increases from Day 0 to 
Day 7. This suggests a shift from cell population 1 to cell population 2, and a 







Figure 38: Enrichment of germ cell marker expression in EOS-C(3+) GFP-
positive cells purified from EBs. Relative gene expression, as quantified by qPCR, is 





Having established that the EB formation is a feasible method for in vitro germ cell 
differentiation, I wanted to test whether Nr5a2 affects germ cell differentiation in 
vitro. Mouse v6.4 ESCs were infected with EOS-C(3+) reporter lentiviruses along 
with either Luciferase or Nr5a2 knockdown lentiviruses. Stable clonal cell lines were 
established after colony picking and several weeks of culture under selection pressure 
(Figure 39a). Concordant to published data (Gu et al., 2005; Guo and Smith, 2010), 
Nr5a2 is not essential for mESC maintenance. The stable Nr5a2 knockdown cell line 
(EOS-Nr5a2) appeared morphologically similar to the control Luciferase knockdown 
cell line (EOS-Luci), with dome-shaped colonies that are positive for the EOS-C(3+) 
EGFP reporter expression (Figure 39b). Both EOS-Luci and EOS-Nr5a2 knockdown 
cells were then subjected to EB formation for seven days. There was no visible 
difference in the EBs that were formed using the EOS-Luci and EOS-Nr5a2 cell lines, 
with uniformly bright GFP expression on Day 1 (Figure 40a) and heterogeneous GFP 
expression by Day 7 (Figure 40b). Furthermore, there was also no obvious distinction 
in the GFP intensity or pattern of the GFP-positive subset (from cell population 2) 
between EOS-Luci and EOS-Nr5a2 (Figure 40c). 
Although the purified GFP-positive fraction is supposedly enriched for putative germ 
cells, as shown previously, it is difficult to exclude the possibility of the presence of 
undifferentiated ESCs which could mask the effect of Nr5a2 knockdown. Therefore, 
the GFP-positive cells (from cell population 2) of both EOS-Luci EBs and EOS-
Nr5a2 EBs were FACS-purified and cultured in EGC-conversion culture medium 
(EGM), which contains three essential growth factors namely, LIF, bFGF and SCF 
(Matsui et al., 1992; Resnick et al., 1992). In addition, retinoic acid (RA) was also 
included in the culture medium to differentiate any residual undifferentiated ESCs, as  
  
Figure 39: Establishment of stable EOS-Luci and EOS-Nr5a2 knockdown mESC 
lines. (a) qPCR data for Nr5a2 levels in stable knockdown cell lines. Data represents 
the mean ± s.e.m. of two technical replicates (n = 2). (b) Phase and fluorescent images 
of EOS-Luci and EOS-Nr5a2 knockdown mESC lines. 
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 Figure 40: EB formation using stable EOS-Luci and EOS-Nr5a2 knockdown 
mESC lines.  Phase and GFP images of embryoid bodies that were generated using 
EOS-Luci and EOS-Nr5a2 mESC on (a) day 1 and (b) day 7. (c) FACS profile of 






well as to promote survival and proliferation of potential germ cells (West et al., 
2006; West et al., 2009). EGC colonies were later detected by alkaline phosphatase 
(AP) staining after 5-7 days in culture. As compared to EOS-Luci, significantly fewer 
AP-positive colonies were observed for EOS-Nr5a2 (Figure 41c,d). As a control, 
GFP-positive cells were also purified from undifferentiated cell lines and grown in 
typical ESC medium (ESM) in the presence of LIF. Although EOS-Nr5a2 also had 
fewer AP-positive colonies than EOS-Luci in ESM conditions (Figure 41a-b), the 
reduction is much more evident for differentiated cells in EGM conditions (Figure 
41c-d). Hence, the effect of Nr5a2 knockdown on the number of AP-positive colonies 
from the germ-cell enriched sorted cells cannot be attributed to potential 
contamination by undifferentiated mESCs. This result then leads us to two 
possibilities: (1) Nr5a2 affects germ cell formation in vitro or (2) Nr5a2 affects the 
conversion efficiency of germ cells to EGC. To investigate further, RNA was 
extracted from the “germ cell-enriched” GFP-positive cells of Day 7 EBs and, 
pluripotency and germ cell marker expression was examined using realtime qPCR. 
While pluripotency factors such as Pou5f1, Sox2 and Nanog were expressed at 
slightly lower levels in the Nr5a2 knockdown GFP-positive cells as compared to 
Luciferase knockdown control, there was a greater reduction in the expression of 
germ cell markers, especially for later germ cell markers such as Dazl, Ddx4, 
Mov10l1, Stra8 and Sycp3 (Figure 41e). Altogether, our data implies that Nr5a2 may 
be important for germ cell differentiation.  
 Figure 41: Nr5a2 plays a role in germ cell formation in vitro. Images and 
quantification of AP-positive colonies that form when GFP-positive EOS-Luci and 
EOS-Nr5a2 cells purified from (a,b) Day 0 and (c,d) Day 7 EBs were cultured in 
ESM and EGM (RA) respectively. Quantitation of AP-positive colonies is expressed 
as a ratio of the respective Luciferase knockdown control frequencies. Data represents 
the mean ± s.e.m. of two biological replicates (n = 2) for ESM and three biological 
replicates (n = 3) for EGM (RA). (e) Realtime qPCR data for pluripotency and germ 
cell markers in GFP-positive cells that were purified from Day 7 EBs. Expression 






Using both ESCs and FACS-purified germ cells, I have demonstrated that ChIP-Seq 
could be achieved from minute starting amounts of DNA or small cell populations. 
The additional WGA amplification step and subsequent procedures to excise PCR 
adaptors do not adversely affect ChIP-Seq results. Genome-wide data of ChIP 
duplicates also suggests reproducibility of the small-scale ChIP procedures. However, 
good quality ChIP-Seq results still depend on purification of sufficient cell numbers 
(at least 50,000 cells) and the availability of good ChIP-grade antibodies. While I 
have generated histone ChIP-Seq libraries, it remains to be tested whether the same 
procedure is adequate for transcription factor ChIP-Seq. Given that DNA yield and 
ChIP enrichment tend to be less for transcription factor ChIP, further optimization 
might be required.  
In this project, I have optimized and performed genome-wide techniques to study in 
vivo germ cells. More specifically, the combination of microarray and ChIP-Seq 
provides a powerful method for mining useful information on transcriptional and 
epigenetic regulation. Microarray analyses suggest that E13.5 germ cells are 
undergoing a transitional period whereby germ cells are driven to differentiate and 
“pluipotential” is lost. Early-changing genes may be important in mediating this 
switch at E13.5. For example, the upregulation of p16INK4A, which was previously 
reported as a barrier to iPSC reprogramming (Li et al., 2009), may explain why germ 
cells cannot revert back to pluripotent EGCs after E12.5 (Labosky et al., 1994), even 
though many pluripotency-associated genes are transcriptionally downregulated only 




Another area of interest is to investigate the similarities and differences between germ 
cells, ESCs and other differentiated cell types, and identify transcription factors that 
contribute to the germ cell identity. The genome-wide maps of H3K4me3, 
H3K27me3, H3K27ac and H2BK20ac in E13.5 male germ cells provide a means to 
determine the activity status of regulatory elements such as promoters and enhancers. 
Taking advantage of publicly available histone modification data for other cell types, 
it is possible to identify promoters and enhancers that are specifically activated in 
germ cells. The enrichment of germ cell related processes and mouse phenotypes also 
render some confidence to biological relevance of these identified regulatory 
elements.  
Going a step further, potential germ cell regulators were identified by undertaking 
several strategies that involve motif analyses and making use of available 
transcription factor ChIP-Seq data. Two such factors, Dmrt1 and Nr5a2, have been 
selected for further in-depth studies. Expression has been validated on the transcript 
and protein level, and both factors are shown to be enriched in germ cells. Although 
Dmrt1 has already been implicated in germ cell development, this study reveals that 
the Dmrt motif is enriched at not only promoters but also active enhancers in E13.5 
male germ cells. Therefore, future ChIP-Seq data of Dmrt1 could yield more insight 
into its downstream targets and enhance our understanding of its regulatory functions 
in germ cells. On the other hand, the discovery of a potential role of Nr5a2 in germ 
cells is novel and not previously reported. Given that Nr5a2 knockout causes 
embryonic lethality  (Botrugno et al., 2004; Gu et al., 2005; Pare et al., 2004) prior to 
the developmental time frame of this study, I have taken an alternative in vitro 
approach to show that Nr5a2 plays a role in germ cell differentiation. However, to be 
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absolutely certain about this conclusion, it is essential to demonstrate the role of 
Nr5a2 in vivo via the generation of a germ cell-specific conditional knockout. 
Lastly, this study demonstrates the feasibility of generating ChIP-Seq data from small 
cell populations and opens the possibility to ChIP other types of rare cells.  
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